ArticleFrontiers in oncology2026

PSCA-directed nanosized bio-immune conjugates (NANO:BICs) enable selective uptake of TLR9 agonists in bladder cancer cells.

Max Iltzsche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.